Macro-TSH in patients with primary hypothyroidism due to autoimmune thyroiditis

Г. Сарибекян, Д. А. Петренко, Д.А. Трухина, А. Г. Кузьмин, Л. К. Дзеранова, Л. В. Никанкина, Г. С. Колесникова, Anna G. Saribekian, D. Petrenko, D. Trukhina, A. Kuzmin, Dzeranova, L. V. Nikankina, Galina S. Kolesnikova
{"title":"Macro-TSH in patients with primary hypothyroidism due to autoimmune thyroiditis","authors":"Г. Сарибекян, Д. А. Петренко, Д.А. Трухина, А. Г. Кузьмин, Л. К. Дзеранова, Л. В. Никанкина, Г. С. Колесникова, Anna G. Saribekian, D. Petrenko, D. Trukhina, A. Kuzmin, Dzeranova, L. V. Nikankina, Galina S. Kolesnikova","doi":"10.14341/ket12710","DOIUrl":null,"url":null,"abstract":"Thyroid stimulating hormone (TSH) is one of the key indicators in the diagnosis of the thyroid gland functional disorders. Minor changes in TSH concentration make it possible to suspect thyroid dysfunction even before clinical manifestations, which increases the value of correct and timely measurement of it. In the clinical practice, an endocrinologist often encounter the well-known phenomenon of macroprolactinemia; a much less common phenomenon is macrotyrotropinemia (macro-TSH). The presence of macro-TSH complexes can be suspected when the serum detects atypically high TSH values with reference values of FT4 without any signs of hypothyroidism. Since the phenomenon is based on an autoimmune mechanism, macro-TSH can often be detected in patients with autoimmune thyroiditis (AIT). This article presents clinical cases of patients with a combination of the macro-TSH phenomenon and primary hypothyroidism due to AIT.","PeriodicalId":10284,"journal":{"name":"Clinical and experimental thyroidology","volume":"34 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and experimental thyroidology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14341/ket12710","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Thyroid stimulating hormone (TSH) is one of the key indicators in the diagnosis of the thyroid gland functional disorders. Minor changes in TSH concentration make it possible to suspect thyroid dysfunction even before clinical manifestations, which increases the value of correct and timely measurement of it. In the clinical practice, an endocrinologist often encounter the well-known phenomenon of macroprolactinemia; a much less common phenomenon is macrotyrotropinemia (macro-TSH). The presence of macro-TSH complexes can be suspected when the serum detects atypically high TSH values with reference values of FT4 without any signs of hypothyroidism. Since the phenomenon is based on an autoimmune mechanism, macro-TSH can often be detected in patients with autoimmune thyroiditis (AIT). This article presents clinical cases of patients with a combination of the macro-TSH phenomenon and primary hypothyroidism due to AIT.
自身免疫性甲状腺炎所致原发性甲状腺功能减退患者的巨量tsh
促甲状腺激素(TSH)是诊断甲状腺功能障碍的关键指标之一。TSH浓度的微小变化可以在临床表现之前就怀疑甲状腺功能障碍,这增加了正确及时测量TSH的价值。在临床实践中,内分泌学家经常会遇到众所周知的巨催乳素血症现象;一种不太常见的现象是大酪蛋白血症(大tsh)。当血清检测到非典型的高TSH值,FT4参考值,而没有甲状腺功能减退的迹象时,可以怀疑存在大TSH复合物。由于这种现象是基于自身免疫机制,因此在自身免疫性甲状腺炎(AIT)患者中经常可以检测到巨量tsh。本文介绍了由AIT引起的大促甲状腺激素现象和原发性甲状腺功能减退合并的临床病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信